TechCrunch: M&A

AUGUST 22, 2023

The company has manufactured hardware for programs including Boeing’s Starliner reusable spacecraft, Sierra Space’s Dream Chaser spaceplane and Airbus OneWeb’s satellite constellation. More recently, the company has turned to manufacturing its own satellites, called LizzieSats, that will operate in low Earth orbit.

Mergers and Acquisitions 246

Mergers and Acquisitions Initial Public Offering Acquisitions Manufacturing 246

Francine Way

JULY 8, 2017

PE funds typically have 4-to-7-years ownership windows for an investment and look for an exit at the end of that period through a sale or an IPO (initial public offering).

M&A 130

M&A Acquisitions Sale Investment 130

Focus Investment Banking

FEBRUARY 25, 2024

First, there’s the ability to raise substantial capital by issuing shares to the public in an initial public offering (IPO), as well as secondary offerings. Lastly, going public is a liquidity event for the founders and early investors, allowing them to cash in on their success.

Private Equity 52

Private Equity IPO Equities Public Trading 52

Growth Business

JULY 11, 2023

3) Aquis Stock Exchange Aquis Stock Exchange , run by NEX, allows businesses to raise capital through Initial Public Offerings (IPOs). >See 13) Asset finance Asset finance is a flexible financing option for businesses and entrepreneurs and is widely available through banks, specialist funders, brokers and many manufacturers.

Finance 75

Finance Finance Business Funds 75

Cooley M&A

JANUARY 25, 2023

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 22, 2025

This approach, combining M&A and initial public offering (IPO) preparations on parallel tracks, allows companies to maximize optionality in an uncertain market. billion acquisition of Catalent, a leader in contract manufacturing for cell and gene therapies, stands out as the largest healthcare deal of 2024.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64